15 years |
Group A, n=33 (%) |
95% CI |
Group B, n=215 (%) |
95% CI |
P-value (χ²) |
Atopic dermatitis |
6 (18%) |
4-32% |
41 (19%) |
14-24% |
10.904 |
Asthma |
10 (30%) |
14-47% |
34 (16%) |
11-21% |
10.044 |
Rhinoconjunctivitis |
12 (36%) |
19-54% |
40 (19%) |
13-24% |
10.020 |
26 years |
Group A, n=33 (%) |
95% CI |
Group B, n=193 (%) |
95% CI |
P-value (χ²) |
Atopic dermatitis |
7 (21%) |
6-36% |
12 (6%) |
3-10% |
10.004 |
Asthma |
10 (30%) |
14-47% |
16 (8%) |
4-12% |
10.000 |
Rhinoconjunctivitis |
14 (42%) |
25-60% |
58 (30%) |
24-37% |
10.159 |